Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 3/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | CXCR3 | P49682 | 8/20 | 0.36 |
| ▸ | AR | P10275 | 1/20 | 0.33 |
| ▸ | ABL1 | P00519 | 1/20 | 0.33 |
| ▸ | LIPE | Q05469 | 1/20 | 0.33 |
| ▸ | CACNA2D1 | P54289 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | CCR6 | P51684 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6173690 | 0.90 | CYP3A4 (0.41) | CYP3A4POLBL3MBTL1GAACYP2C9 | |
| SCHEMBL6172003 | 0.87 | ALDH1A1 (0.37) | CYP3A4POLBL3MBTL1GAACYP2C9 | |
| SCHEMBL6173429 | 0.86 | POLB (0.41) | CYP3A4POLBL3MBTL1GAACYP2C9 | |
| SCHEMBL6177840 | 0.86 | IGF1R (0.43) | AR | |
| SCHEMBL6174774 | 0.85 | SLC5A1 (0.40) | CYP3A4POLBL3MBTL1GAACYP2C9 | |
| SCHEMBL6170701 | 0.85 | IGF1R (0.37) | CYP3A4GAACYP2C9CYP2C19ALDH1A1 | |
| SCHEMBL6170901 | 0.85 | CYP3A4 (0.35) | CYP3A4POLBL3MBTL1GAACYP2C9 | |
| SCHEMBL6173440 | 0.85 | CYP3A4 (0.38) | CYP3A4POLBL3MBTL1GAACYP2C9 | |
| SCHEMBL6175704 | 0.85 | POLB (0.36) | CYP3A4POLBL3MBTL1GAACYP2C9 | |
| SCHEMBL6173276 | 0.83 | CYP3A4 (0.35) | CYP3A4POLBL3MBTL1GAACYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1599464-B1 | NOVEL CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS | AVENTIS PHARMA SA (FR) | 2010-09-22 | — | — | EP | disclosed |